Find out if your patients may be candidates for two studies now enrolling for solid tumors and pain resulting from head and neck cancer.
Category: Clinical Trial
As a renowned heart center that excels in valve surgery, UVA has taken significant steps over the past decade to find alternative solutions to make treatment for mitral valve regurgitation safer, easier and more effective.
Focused ultrasound temporarily opens the blood-brain barrier to allow the delivery of more cancer-fighting agent to the tumor.
View a list of trials now enrolling at UVA Heart & Vascular Center.
Learn more about the SALT Study and a trial focusing on developing a sentinel lymph node mapping (SLNm) technique for patients with early-stage rectal cancer.
An expert in immunotherapy, Lawrence G. Lum, MD, DSc joins UVA Cancer Center as the scientific director of bone marrow transplantation. One of Lum’s priorities is pioneering a new method of activating the body’s own T cells to target tumor cells.
High-grade glioma patients at UVA now have the opportunity to participate in Toca 5, an international clinical trial of a new, virus-based procedure that activates therapeutics selectively within the brain tumor, leading to fewer side effects.
Precision Breast IORT is a unique form of IORT developed at UVA — now being examined in a Phase II clinical trial — that incorporates CT imaging and high-dose rate (HDR) brachytherapy.
Find out if your patients are eligible for the next-generation LVAD treatment or novel stem cell therapy, now being examined by leading heart specialists at UVA.
Mark B. Williams, PhD, has devoted the past decade to developing a new scanner that he hopes will give women and their physicians better diagnostic information.